Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Behrens

Showing results (11-20 of 39) with videos related to

Pageof 4
Sort By:
Plos One|May 20, 2016
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial TherapyJosep M Llibre, François Raffi, Graeme Moyle, et al.
European Journal of Medical Research|June 22, 2022
Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trialDominik Schröder, Stephanie Heinemann, Gloria Heesen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2019
Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure TrialsMelanie Stecher, Annika Claßen, Florian Klein, et al.
Plos One|October 17, 2012
Absence of Foxp3+ regulatory T cells during allergen provocation does not exacerbate murine allergic airway inflammationAbdul Mannan Baru, Venkateswaran Ganesh, Jayendra Kumar Krishnaswamy, et al.
Plos One|February 8, 2014
Delineating the role of histamine-1- and -4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammationSubhashree Mahapatra, Melanie Albrecht, Barbara Behrens, et al.
International Journal of Telemedicine and Applications|January 1, 2026
Acceptability of Telehealth-Delivered Occupational Therapy Among Individuals With Long COVID Using the Theoretical Framework of Acceptability: A Qualitative StudyChristina Müllenmeister, Gloria Königs, Stephanie Heinemann, et al.
Frontiers in Public Health|June 27, 2022
The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons - Results of a Multicenter Observational StudyGloria Heesen, Dominik Schröder, Frank Müller, et al.
Journal of Hepatology|March 24, 2009
Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatmentTim O Lankisch, Georg Behrens, Ursula Ehmer, et al.
The Journal of Infectious Diseases|October 12, 2011
Comparative analysis of Ebola virus glycoprotein interactions with human and bat cellsAnnika Kühl, Markus Hoffmann, Marcel A Müller, et al.
Archives of Public Health = Archives Belges De Sante Publique|August 25, 2023
Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP studyFrederik Valbert, Uwe Koppe, Daniel Schmidt, et al.
Pageof 4

Showing results (11-20 of 39) with videos related to

Sort By:
Pageof 4
Plos One|May 20, 2016
An Indirect Comparison of Efficacy and Safety of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate and Abacavir/Lamivudine + Dolutegravir in Initial TherapyJosep M Llibre, François Raffi, Graeme Moyle, et al.
European Journal of Medical Research|June 22, 2022
Who is pausing immunosuppressive medication for COVID-19 vaccination? Results of an exploratory observational trialDominik Schröder, Stephanie Heinemann, Gloria Heesen, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 19, 2019
Systematic Review and Meta-analysis of Treatment Interruptions in Human Immunodeficiency Virus (HIV) Type 1-infected Patients Receiving Antiretroviral Therapy: Implications for Future HIV Cure TrialsMelanie Stecher, Annika Claßen, Florian Klein, et al.
Plos One|October 17, 2012
Absence of Foxp3+ regulatory T cells during allergen provocation does not exacerbate murine allergic airway inflammationAbdul Mannan Baru, Venkateswaran Ganesh, Jayendra Kumar Krishnaswamy, et al.
Plos One|February 8, 2014
Delineating the role of histamine-1- and -4-receptors in a mouse model of Th2-dependent antigen-specific skin inflammationSubhashree Mahapatra, Melanie Albrecht, Barbara Behrens, et al.
International Journal of Telemedicine and Applications|January 1, 2026
Acceptability of Telehealth-Delivered Occupational Therapy Among Individuals With Long COVID Using the Theoretical Framework of Acceptability: A Qualitative StudyChristina Müllenmeister, Gloria Königs, Stephanie Heinemann, et al.
Frontiers in Public Health|June 27, 2022
The Impact of COVID-19 Vaccination on the Social Participation of Immunocompromised Persons - Results of a Multicenter Observational StudyGloria Heesen, Dominik Schröder, Frank Müller, et al.
Journal of Hepatology|March 24, 2009
Gilbert's syndrome and hyperbilirubinemia in protease inhibitor therapy--an extended haplotype of genetic variants increases risk in indinavir treatmentTim O Lankisch, Georg Behrens, Ursula Ehmer, et al.
The Journal of Infectious Diseases|October 12, 2011
Comparative analysis of Ebola virus glycoprotein interactions with human and bat cellsAnnika Kühl, Markus Hoffmann, Marcel A Müller, et al.
Archives of Public Health = Archives Belges De Sante Publique|August 25, 2023
Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP studyFrederik Valbert, Uwe Koppe, Daniel Schmidt, et al.
Pageof 4